Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage

In light of an aging population with increased cardiovascular comorbidity, the use of oral anticoagulation (OAC) is steadily expanding. A variety of pharmacological alternatives to vitamin K antagonists (VKA) have emerged over recent years (direct oral anticoagulants, DOAC, i.e., dabigatran, rivarox...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuramatsu, Joji B., Sembill, Jochen A., Huttner, Hagen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555738/
https://www.ncbi.nlm.nih.gov/pubmed/31171018
http://dx.doi.org/10.1186/s13054-019-2492-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555738/
https://www.ncbi.nlm.nih.gov/pubmed/31171018
http://dx.doi.org/10.1186/s13054-019-2492-8

Ejemplares similares